Current Pharmaceutical Design
Title: Preface [ Hot Topic: Autoimmunity (Executive Editor : Dorothea Stahl)]
Volume: 9 Issue: 23
Author(s): Dorothea Stahl
Affiliation:
Export Options
About this article
Cite this article as:
Stahl Dorothea, Preface [ Hot Topic: Autoimmunity (Executive Editor : Dorothea Stahl)], Current Pharmaceutical Design 2003; 9 (23) . https://dx.doi.org/10.2174/1381612033454342
DOI https://dx.doi.org/10.2174/1381612033454342 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Article Metrics

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Perspectives and New Aspects of Metalloproteinases’ Inhibitors in the Therapy of CNS Disorders: From Chemistry to Medicine
Current Medicinal Chemistry Editorial: (Thematic Issue Cancer Immunotherapy: Does an Increasing Arsenal of Tools Point to More Fruitful Avenues for Research?)
Anti-Cancer Agents in Medicinal Chemistry Cancer Immunotherapy: An Effective Tool in Cancer Control and Treatment
Current Cancer Therapy Reviews The Emergence of Non-coding RNAs as Versatile and Efficient Therapeutic Tools
Current Gene Therapy In Vivo Cellular Imaging for Translational Medical Research
Current Medical Imaging Development of Drug Targeting and Delivery in Cervical Cancer
Current Cancer Drug Targets Future Prospect of RNA Interference for Cancer Therapies
Current Drug Targets DNA Fragmentation, Cell Cycle Arrest, and Docking Study of Novel Bis Spiro-cyclic 2-oxindole of Pyrimido[4,5-b]quinoline-4,6-dione Derivatives Against Breast Carcinoma
Current Cancer Drug Targets N-Oxides as Hypoxia Selective Cytotoxins
Mini-Reviews in Medicinal Chemistry In-silico Designing of Novel Camptothecin Analogues as Potent Inhibitors of Topoisomerase I: A Molecular Docking, QSAR, and ADME-T Study
Letters in Drug Design & Discovery PARP Inhibitor Drugs in the Treatment of Breast, Ovarian, Prostate and Pancreatic Cancers: An Update of Clinical Trials
Current Drug Targets Synthesis and Biological Evaluation of 3΄-C-Ethynyl and 3΄-C-(1,4-disubstituted-1,2,3-triazolo) Double-Headed Pyranonucleosides
Medicinal Chemistry in vitro Anti-leukaemia Activity of Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs)
Recent Patents on Anti-Cancer Drug Discovery CDK12 Promotes Breast Cancer Progression and Maintains Stemness by Activating c-myc/β -catenin Signaling
Current Cancer Drug Targets New Light on An Old Friend: Targeting PUMA in Radioprotection and Therapy of Cardiovascular and Neurodegenerative Diseases
Current Drug Targets Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational Option
Current Topics in Medicinal Chemistry Applications of Venom Proteins as Potential Anticancer Agents
Protein & Peptide Letters Mitochondrial Dysfunction and Lipid Homeostasis
Current Drug Metabolism Circulating Tumor Cells: A New Window for Diagnosis and Evaluation of Cancer
Anti-Cancer Agents in Medicinal Chemistry The Roles of Vitamin D and Its Analogs in Inflammatory Diseases
Current Topics in Medicinal Chemistry